• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与KIT突变和白癜风相关的无色素性肢端黑色素瘤

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo.

作者信息

Kim Young Jee, Lee Jee-Bum, Kim Seong-Jin, Lee Seung-Chul, Won Young Ho, Yun Sook Jung

机构信息

Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Ann Dermatol. 2015 Apr;27(2):201-5. doi: 10.5021/ad.2015.27.2.201. Epub 2015 Mar 24.

DOI:10.5021/ad.2015.27.2.201
PMID:25834362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4377412/
Abstract

Amelanotic acral melanoma is rare and difficult to diagnose, both clinically and pathologically. KIT mutations are frequently found in acral melanomas and are considered a risk factor for poor prognosis. The presence of vitiligo in melanoma has been reported, and KIT is thought to be partly responsible for the dysfunction and loss of melanocytes observed in vitiligo. We report a case of amelanotic subungual melanoma with multiple metastases that was associated with KIT mutation and vitiligo. An 85-year-old man presented with a 3-year history of a tender erythematous ulcerated tumor on the left third fingertip and developed hypopigmented patches on the face and trunk. Histopathological examination of the ulcerative tumor showed aggregates of tumor cells that were pleomorphic epithelioid cells. Immunohistochemical staining of the tumor cells was positive for S100, HMB45, and c-Kit. Histopathological findings from the hypopigmented patch on the face were consistent with vitiligo. Mutation analysis showed a KIT mutation in exon 17 (Y823D). The patient had metastasis to the brain, liver, bone, and both lungs. The patient refused chemotherapy, and died 3 months after the first visit.

摘要

无色素性肢端黑色素瘤罕见,在临床和病理上均难以诊断。KIT突变在肢端黑色素瘤中经常被发现,被认为是预后不良的一个危险因素。黑色素瘤中白癜风的存在已有报道,并且KIT被认为部分导致了白癜风中观察到的黑素细胞功能障碍和缺失。我们报告一例伴有多发转移的无色素性甲下黑色素瘤病例,该病例与KIT突变和白癜风相关。一名85岁男性,左手中指指尖出现一个压痛性红斑溃疡性肿瘤,病史3年,面部和躯干出现色素减退斑。对溃疡性肿瘤进行组织病理学检查显示肿瘤细胞聚集,为多形性上皮样细胞。肿瘤细胞的免疫组化染色S100、HMB45和c-Kit呈阳性。面部色素减退斑的组织病理学表现与白癜风一致。突变分析显示第17外显子(Y823D)存在KIT突变。该患者发生了脑、肝、骨和双肺转移。患者拒绝化疗,首次就诊3个月后死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/6fcfa988dddc/ad-27-201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/7353e22c0cd5/ad-27-201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/651218b01cdf/ad-27-201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/aef12008093d/ad-27-201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/6fcfa988dddc/ad-27-201-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/7353e22c0cd5/ad-27-201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/651218b01cdf/ad-27-201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/aef12008093d/ad-27-201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d651/4377412/6fcfa988dddc/ad-27-201-g004.jpg

相似文献

1
Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo.与KIT突变和白癜风相关的无色素性肢端黑色素瘤
Ann Dermatol. 2015 Apr;27(2):201-5. doi: 10.5021/ad.2015.27.2.201. Epub 2015 Mar 24.
2
Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses.无色素性肢端黑素瘤:临床病理、BRAF 突变和 KIT 异常分析。
J Am Acad Dermatol. 2013 Nov;69(5):700-707. doi: 10.1016/j.jaad.2013.06.035. Epub 2013 Aug 21.
3
Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.分析肢端黑色素瘤中 KIT 的表达和基因突变:与原发肿瘤和相应转移/复发的比较。
Hum Pathol. 2013 Aug;44(8):1472-8. doi: 10.1016/j.humpath.2013.01.007. Epub 2013 Mar 22.
4
Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases.黏膜黑色素瘤:86 例法国病例的临床、组织学和 c-kit 基因突变特征。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1834-1840. doi: 10.1111/jdv.14353. Epub 2017 Jun 14.
5
Unusual location of subungual amelanotic melanoma in 39-year-old patient: a rare case report.39岁患者甲下无黑色素性黑色素瘤的罕见部位:一例罕见病例报告
Ann Med Surg (Lond). 2024 Feb 28;86(4):2314-2317. doi: 10.1097/MS9.0000000000001860. eCollection 2024 Apr.
6
[ Spectrum of oncogene mutations is different in melanoma subtypes].[黑色素瘤亚型中癌基因突变谱不同]
Mol Biol (Mosk). 2015 Nov-Dec;49(6):1022-9. doi: 10.7868/S0026898415060166.
7
Primary acral amelanotic melanoma: A rare case report.原发性肢端无色素性黑色素瘤:一例罕见病例报告。
Mol Clin Oncol. 2020 Nov;13(5):59. doi: 10.3892/mco.2020.2129. Epub 2020 Sep 3.
8
Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi.非典型肢端痣中CKIT免疫组化表达与KIT突变之间缺乏相关性。
Am J Dermatopathol. 2012 Feb;34(1):41-6. doi: 10.1097/DAD.0b013e31821ec0ef.
9
A Rare Case of Oral Mucosal Amelanotic Melanoma in a 77-year-old Immunocompromised Man.一名77岁免疫功能低下男性患口腔黏膜无色素性黑色素瘤的罕见病例。
J Clin Aesthet Dermatol. 2021 Jan;14(1):27-29. Epub 2021 Jan 1.
10
Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment.一名接受纳武单抗治疗的无色素性黑色素瘤患者的白癜风与肿瘤反应
Int Cancer Conf J. 2021 Oct 12;11(1):46-48. doi: 10.1007/s13691-021-00515-w. eCollection 2022 Jan.

引用本文的文献

1
Acral Amelanotic Melanoma With a Sporotrichoid Pattern and Associated Vitiligo in an Elderly Patient: A Case Report.老年患者伴孢子丝菌样模式及白癜风的肢端无色素性黑素瘤:1例报告
Cureus. 2025 Jul 23;17(7):e88630. doi: 10.7759/cureus.88630. eCollection 2025 Jul.
2
A rare case of acral amelanotic melanoma, nodular type.肢端无色素性结节型黑素瘤 1 例罕见报告。
Int Wound J. 2019 Dec;16(6):1445-1449. doi: 10.1111/iwj.13212. Epub 2019 Sep 18.
3
Subungual Amelanotic Melanoma Masquerading as Onychomycosis.伪装成甲癣的甲下无色素性黑色素瘤

本文引用的文献

1
Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.韩国患者原发性肢端雀斑样痣黑色素瘤中BRAF突变的预后及临床病理相关性:一项初步研究
Ann Dermatol. 2014 Apr;26(2):195-202. doi: 10.5021/ad.2014.26.2.195. Epub 2014 Apr 30.
2
Amelanotic acral melanomas: clinicopathological, BRAF mutation, and KIT aberration analyses.无色素性肢端黑素瘤:临床病理、BRAF 突变和 KIT 异常分析。
J Am Acad Dermatol. 2013 Nov;69(5):700-707. doi: 10.1016/j.jaad.2013.06.035. Epub 2013 Aug 21.
3
BRAF and KIT somatic mutations are present in amelanotic melanoma.
Cureus. 2018 Mar 11;10(3):e2307. doi: 10.7759/cureus.2307.
4
Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.白癜风皮损表皮c-Kit+的表达与准分子激光治疗反应相关。
Ann Dermatol. 2016 Aug;28(4):457-63. doi: 10.5021/ad.2016.28.4.457. Epub 2016 Jul 26.
无色素性黑色素瘤中存在BRAF和KIT体细胞突变。
Melanoma Res. 2013 Oct;23(5):414-9. doi: 10.1097/CMR.0b013e32836477d4.
4
BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas.202例韩国黑色素瘤患者中BRAF突变、KIT畸变及其临床病理相关性
J Invest Dermatol. 2013 Feb;133(2):579-82. doi: 10.1038/jid.2012.338. Epub 2012 Sep 27.
5
Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.无色素性黑色素瘤:75例临床病理相关性的详细形态学分析
J Cutan Pathol. 2012 Jan;39(1):33-9. doi: 10.1111/j.1600-0560.2011.01808.x. Epub 2011 Nov 3.
6
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.甲磺酸伊马替尼治疗伴有 c-Kit 突变或扩增的转移性黑色素瘤患者的 II 期、开放标签、单臂试验。
J Clin Oncol. 2011 Jul 20;29(21):2904-9. doi: 10.1200/JCO.2010.33.9275. Epub 2011 Jun 20.
7
Large amelanotic melanoma and vitiligo.巨大无色素性黑素瘤与白癜风。
Arch Dermatol. 2009 Oct;145(10):1198-9. doi: 10.1001/archdermatol.2009.249.
8
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.白癜风是 III 期和 IV 期转移性黑色素瘤患者的独立有利预后因素:来自单机构基于医院的观察队列研究的结果。
Ann Oncol. 2010 Feb;21(2):409-414. doi: 10.1093/annonc/mdp325. Epub 2009 Jul 21.
9
Imatinib mesylate-induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors.甲磺酸伊马替尼诱导一名复发性胃肠道间质瘤患者白癜风皮损重新色素沉着。
J Am Acad Dermatol. 2008 Nov;59(5 Suppl):S80-3. doi: 10.1016/j.jaad.2008.06.029.
10
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma.转移性黑色素瘤维持生物治疗期间白癜风表达与生存率提高相关。
J Invest Dermatol. 2006 Dec;126(12):2658-63. doi: 10.1038/sj.jid.5700545. Epub 2006 Aug 31.